C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01) A61K 31/47 (2006.01)
Patent
CA 2734831
Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.
La présente invention concerne les composés de formule (I), dans laquelle A, B, R1, R1a, R2, R3, R4, R5, R6, et R7 ont les significations données dans la spécification, qui sont des inhibiteurs de la tyrosine du récepteur utiles dans le traitement de maladies et troubles associés aux cellules immunitaires, tels que les maladies inflammatoires et auto-immunes.
Allen Shelley
Celeste Laura L.
Davis T. Gregg
Delisle Robert Kirk
Greschuk Julie Marie
Array Biopharma Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Triazolopyridine compounds as pim kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyridine compounds as pim kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyridine compounds as pim kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1449423